RADIOACTIVE OCCURRENCES AND URANIUM PRODUCTION IN ARIZONA; FINAL REPORT = OCCURRENCES RADIOACTIVES ET PRODUCTION D'URANIUM EN ARIZONA; RAPPORT FINALSCARBOROUGH ROBERT B.1981; ; USA; DA. 1981-03; GJBX/143-81; 297; BIBL. 504 REF.; ILL.Report

Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers : Novel parenteral and potential oral antithrombotic agentsSCARBOROUGH, Robert M; GRETLER, Daniel D.Journal of medicinal chemistry (Print). 2000, Vol 43, Num 19, pp 3453-3473, issn 0022-2623Article

CENOZOIC SEDIMENTS, VOLCANICS, AND RELATED URANIUM IN THE BASIN AND RANGE PROVINCE OF ARIZONAWILT JAN C; SCARBOROUGH ROBERT B; GOODELL PHILIP C ED et al.1981; AAPG STUD. GEOL.; ISSN 0271-8510; USA; DA. 1981; NO 13; PP. 123-143; BIBL. 100 REF.; 1 TAB. ; ILL.Conference Paper

Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4BODART, Veronique; ANASTASSOV, Virginia; PATEL, Ketan et al.Biochemical pharmacology. 2009, Vol 78, Num 8, pp 993-1000, issn 0006-2952, 8 p.Article

Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy VolunteersNYUNT, Myaing M; BECKER, Stephen; MACFARLAND, Ron T et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 5, pp 559-565, issn 1525-4135, 7 p.Article

Hydroxamate based inhibitors of adenylyl cyclase. Part 2: The effect of cyclic linkers on P-site bindingLEVY, Daniel E; MING BAO; TOMLINSON, James E et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 21, pp 3089-3092, issn 0960-894X, 4 p.Article

The roles of anoxia, H₂S, and storm events in fish kills of dead-end canals of Delaware inland baysLUTHER, George W; SHUFEN MA; TROUWBORST, Robert et al.Estuaries. 2004, Vol 27, Num 3, pp 551-560, issn 0160-8347, 10 p.Article

Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitorsTING SU; HUA YANG; VOLKOTS, Deborah et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 4, pp 729-732, issn 0960-894X, 4 p.Article

Metal coordination-based inhibitors of adenylyl cyclase: Novel potent p-site antagonistsLEVY, Daniel E; MING BAO; CHERBAVAZ, Diana B et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 11, pp 2177-2186, issn 0022-2623, 10 p.Article

Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors : P4 SARPENGLIE ZHANG; LIANG BAO; JINGMEI FAN et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 8, pp 2186-2189, issn 0960-894X, 4 p.Article

Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitorsPENGLIE ZHANG; ZUCKETT, Jingmei F; HOLLENBACH, Stan et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 12, pp 1657-1661, issn 0960-894XArticle

Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase familyPANDEY, Anjali; VOLKOTS, Deborah L; SCARBOROUGH, Robert M et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 17, pp 3772-3793, issn 0022-2623Article

Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: Synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanesMEHROTRA, Mukund M; HEATH, Julie A; PANDEY, Anjali et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 7, pp 1103-1107, issn 0960-894XArticle

Substituted acrylamides as factor Xa inhibitors: Improving bioavailability by P1 modificationYONGHONG SONG; CLIZBE, Lane; SCARBOROUGH, Robert M et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 15, pp 2043-2046, issn 0960-894XArticle

Hydroxamate based inhibitors of adenylyl cyclase. Part 1: The effect of acyclic linkers on P-site bindingLEVY, Daniel E; MARLOWE, Charles; KANE-MAGUIRE, Kim et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 21, pp 3085-3088, issn 0960-894X, 4 p.Article

Design and synthesis of factor Xa inhibitors and their prodrugsYONGHONG SONG; CLIZBE, Lane; SCARBOROUGH, Robert M et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 2, pp 297-300, issn 0960-894X, 4 p.Article

Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P₁ Structure-activity relationships of the substituted 1-(2-naphthyl)-1H-pyrazole-5-carboxylamidesZHAOZHONG J. JIA; YANHONG WU; REED, Andrea et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 12, pp 1651-1655, issn 0960-894XArticle

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activityPENGLIE ZHANG; LIANG BAO; HOLLENBACH, Stanley J et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 4, pp 989-993, issn 0960-894X, 5 p.Article

Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitorsWENRONG HUANG; NAUGHTON, Mary Ann; SCARBOROUGH, Robert M et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 4, pp 723-728, issn 0960-894X, 6 p.Article

Design, synthesis, and SAR of amino acid derivatives as factor Xa inhibitorsTING SU; YANHONG WU; ZHU, Bing-Yan et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 22, pp 2947-2950, issn 0960-894XArticle

Inhibitory effect of carboxylic acid group on hERG bindingZHU, Bing-Yan; JIA, Zhaozhong J; SCARBOROUGH, Robert M et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 21, pp 5507-5512, issn 0960-894X, 6 p.Article

Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptorHEATH, Julie A; MEHROTRA, Mukund M; SHANNON CHI et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 19, pp 4867-4872, issn 0960-894X, 6 p.Article

Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y₁₂)SCARBOROUGH, Robert M; LAIBELMAN, Alan M; CLIZBE, Lane A et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 14, pp 1805-1808, issn 0960-894XArticle

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 2: A survey of P4 motifsJIA, Zhaozhong J; YANHONG WU; HUTCHALEELAHA, Athiwat et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 5, pp 1221-1227, issn 0960-894X, 7 p.Article

Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: Implications for identification of therapeutically active inhibitorsSINHA, Uma; PEI HUA LIN; CLIZBE, Lane et al.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 6, pp 1098-1104, issn 1079-5642, 7 p.Article